Lowering Risks for Heart Patients with Fish Oil
New options for patients with cardiovascular risk come in the form of a newer medication recently tested through a clinical trial at Brigham and Women’s Hospital. The drug, a prescription-strength form of purified omega-3 fatty acid EPA, was found to significantly reduce the risk of death in patients with elevated triglyceride levels.
Educational Opportunities, Specialty Care Bring Health Equity to Native Americans
Our country’s 5.2 million Native Americans represent around 1.7% of the U.S. population—but only .56% of active physicians and .48% of full-time faculty members at U.S. medical schools and teaching hospitals nationwide.
Taking a Stand on Immigrants’ Health and Well-being
On October 10, the US Department of Homeland Security issued a proposed change in federal immigration policy that would have a major impact on the health and well-being of millions of legal residents – hundreds of thousands here in Massachusetts.
Building a Brain To Trace Genetic Roots of Mental Illness
It may sound like a special effect engineered for the silver screen, but it’s a reality in Brigham and Women’s Hospital labs: mini brains, grown from human stem cells, that let researchers manipulate genes to study how certain mutations lead to mental illness.
Investigating the Root Causes of Chronic Pain
After injury or surgery, patients are often asked to rank their pain on a scale of 0-10, a way of evaluating a mostly subjective phenomenon. But what if a patient’s pain never fully dissipates? That’s the case for as many as 50 million Americans, who live with chronic pain.
New Fronts in the Fight Against Breast Cancer
As Breast Cancer Awareness Month is observed nationwide through October, the Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) is mobilized on several fronts to treat—and someday prevent—the disease, the second most common cancer in women.